Biogas additives have a place in a well-operated plant, but the place they occupy is always the last, never the first. When applied without a prior diagnosis, the most likely outcome is an ROI below 1x within 12 months, a sustained loss, and a recurring annual cost of between €30,000 and €80,000 in a 1 MWe plant. This article explains why the “magic solution” is statistically unfeasible, which three operational symptoms an additive will never solve, when it does pay off to apply chemistry to the digester, and which five technical questions to ask any supplier before signing a contract.
The efficacy of biogas additives is one of the most poorly framed technical debates in the sector. The operator’s usual question is “do they work or not?”, and that question has no useful answer.
The correct question is: under which operating conditions, on which previously diagnosed limiting factor, and with which quantitative success criteria can an additive deliver a measurable return?
When that question is answered rigorously, additives have a narrow but real profile: improvements of 7 to 18% on specific productivity, in specific scenarios, with ROI above 1.8x. When it is omitted and the additive is applied by default to any suboptimal digester, the sector data are damning: more than 70% of commercial pilots have no prior quantitative criterion and the actual measured improvement falls well below the promised one.
This article describes the “magic solution” pattern, the operational symptoms that no additive can resolve, and a practical protocol to tell a supplier with a technical basis from one without.
What is sold as a “magic solution” in biogas additives
The commercial pattern is always the same and is easy to recognise once you know what to look for.
A supplier arrives with a formulated product (enzyme mix, mineral supplement, biocatalyst, metallic nanoparticle, selected microorganisms) and an application proposal that usually includes these five elements:
- Promised improvement of 15 to 30% in biogas production, specific productivity or VS removal.
- Standard dosing with no prior analytical characterisation of the substrate or the consortium.
- Short trial period (often 30 days, almost never more than 60).
- No simultaneous control (no comparison reactor or statistically valid baseline).
- Implicit attribution of any favourable variation observed to the product, without separating the improvement from the natural variability of the process.
The problem is not that the products are of poor quality. Some have a solid biochemical basis and peer-reviewed publications. The problem is the method by which they are applied: without a prior diagnosis, without success criteria signed before the pilot, and without separating the product’s effect from the process noise.
The attribution bias when a biogas additive “doesn’t work”
When an additive is applied without a prior diagnosis and production does not improve, the system attributes the failure to the product. The typical conclusion is: “let’s try a different additive.”
The correct technical conclusion would be different. The digester was in a regime where no additive could work, because the limiting factor was operational (not biochemical), because the diet was not stable during the trial, or because the dose was not appropriate to the digester’s actual volume.
Three concrete examples of the attribution bias:
Example 1 · Enzyme additive on an overloaded digester
Actual organic loading rate (OLR) 20% above nominal. The bottleneck is thermodynamic (propionic accumulation), not enzymatic. The additive cannot act because the kinetics are not enzyme-limited, but limited by the system’s bioenergetics. Result: “the additive doesn’t work”. Real diagnosis: the OLR was misconfigured.
Example 2 · Mineral supplement on a digester with free NH3
Sustained inhibition by free ammonia at 600 mg N/L. Methanogenesis is blocked by the free NH3 fraction, not by a lack of cofactors. The additive cannot act because the enzymatic activity is no longer present. Result: “the additive doesn’t work”. Real diagnosis: the diet concentrated more nitrogen than the consortium could tolerate without acclimation.
Example 3 · Iron nanoparticle on a digester with poor mixing
The spatial distribution of the additive in the digester is very heterogeneous due to a lack of effective mixing. The additive never reaches the active consortium at a relevant concentration. Result: “the additive doesn’t work”. Real diagnosis: the problem is mechanical, not biochemical.
In all three examples, the additive was paid for, the digester did not improve, and the hasty conclusion was to discard the product. The structural limiting factor was never touched.
Three symptoms no additive resolves
Before considering any chemical intervention, it is worth identifying whether the plant presents any of these three symptoms. If it does, no additive will resolve them.
| Operational symptom | Why no additive resolves it | Correct intervention |
|---|---|---|
| Sustained organic overload (OLR > specific limit) | The bottleneck is thermodynamic (dissolved H₂ pressure). No additive modifies the system’s thermodynamics | Reduce load until FOS/TAC < 0.4 |
| Free NH3 inhibition > 700 mg N/L | Methanogenesis is enzymatically blocked. No cofactor reactivates enzymes inhibited by NH3 | Dilution, corrective co-digestion or directed acclimation |
| Insufficient mixing or dead zones | The additive does not reach the active consortium at a relevant concentration. The problem is mechanical | Review the mixing regime or geometry |
Any attempt to resolve these three symptoms with catalytic additives is, statistically, a waste of money. More detail on how to identify the real limiting factor in the post on stabilising the anaerobic digester.
When it does make sense to apply chemistry to the digester
Applying additives has a solid technical basis when these three conditions are met simultaneously:
- Condition 1 · Complete prior diagnosis that identifies a specific biochemical limiting factor (electron-transfer deficit, lack of trace cofactors, inhibition by dissolved sulphides in the 200–500 mg S/L range).
- Condition 2 · Match between the additive’s mechanism and the limiting factor’s mechanism. The additive must act precisely on the diagnosed bottleneck, not on a generic one.
- Condition 3 · Quantitative success criteria signed before the pilot: minimum increase in specific productivity, stability via FOS/TAC and minimum 12-month ROI.
When the three conditions are met, the real improvement ranges measured in the peer-reviewed scientific literature are 7 to 18% on specific productivity, with ROI between 1.8x and 4x depending on the case. Those numbers are significantly lower than the 15–30% promised by most suppliers, but they are real and sustainable.
The full methodological framework for when to apply advanced tools is described in detail in the post on the additives protocol.
How to evaluate an additives supplier: 5 key questions
Before signing any supply or pilot contract, the following five questions allow you to tell a supplier with a technical basis from one without. A serious supplier answers all five concretely. A supplier without a technical basis dodges at least three.
Question 1 · Which exact biochemical mechanism acts on the limiting factor?
Expected answer: a specific description (DIET via electrical conductivity, trace cofactor supplementation Ni/Co/Fe, sulphide precipitation as FeS, enzymatic biocatalysis of hydrolysis). Red flag: generic terms such as “bacterial stimulation”, “advanced biocatalyst” or “patented technology” with no further detail.
Question 2 · Which peer-reviewed publications support that mechanism?
Expected answer: specific references to papers in Bioresource Technology, Water Research or equivalents, ideally with independent authorship. Red flag: “confidential internal studies” or references only to the manufacturer’s own publications.
Question 3 · What exact dose do you propose and based on which variable?
Expected answer: a dose specified per kg of VS fed or per m³ of reactor, with prior analytical characterisation of the substrate. Red flag: a generic dose with no prior characterisation or “dosing as needed”.
Question 4 · What minimum pilot duration do you recommend and why?
Expected answer: a minimum of 60 days after the initial dosing, justified by the reactor’s HRT and the consortium’s adaptation time. Red flag: pilots of 30 days or less, especially if the supplier insists that “the effect shows up right away”.
Question 5 · Which quantitative criteria would you sign as a success condition?
Expected answer: a minimum increase in specific productivity (≥7%), FOS/TAC below threshold for 80% of the period, minimum 12-month ROI, with no re-dosing. Red flag: “noticeable improvement”, “positive trend” or “the operator will see the difference”.
Operational case: 1 MWe plant facing three additive offers
A 1 MWe agro-industrial plant with low historical specific productivity (0.28 Nm³ CH4/kg VS). Three suppliers come forward with different offers.
| Supplier | Promise | Annual cost | Prior diagnosis |
|---|---|---|---|
| A · Enzyme additive | 25% improvement in biogas | €52,000 | Not included |
| B · Mineral supplement | 18% improvement in CH4 | €38,000 | Not included |
| C · Fe nanoparticle | 12–15% improvement in CH4 | €45,000 | Included in the proposal |
All three promises sound attractive. The key difference is in the last column: only supplier C makes the dosing conditional on a prior diagnosis.
The independent Smallops diagnosis identifies that the real limiting factor is chronic propionic accumulation (1,700 mg/L) due to a hidden overload from a seasonal substrate. No enzyme additive can resolve it (the thermodynamics are adverse). No mineral supplement can resolve it (there is no cofactor deficit). Conductive nanoparticles could help via the DIET mechanism, but only after first reducing the OLR to pull the system out of the propionic zone.
Technical decision
Reject suppliers A and B (they do not act on the diagnosed limiting factor). Accept supplier C but only in phase 2, after a first phase of operational correction.
Result at 6 months
Consolidated results. Phase 1 (operational correction, no additive): productivity 0.28 → 0.34 Nm³ CH4/kg VS (+21%). Phase 2 (additive applied after the correction): 0.34 → 0.38 Nm³ CH4/kg VS (+12%). Total cumulative improvement: +36% over historical productivity.
Total intervention cost (diagnosis included): €38,000. 12-month ROI: 3.2x (versus the <1x estimated had any of suppliers A or B been accepted without a prior diagnosis).
Frequently asked questions about biogas additives
Do biogas additives really work?
Some do and some don’t. Additives with a solid biochemical basis (conductive nanoparticles for DIET, trace cofactors Ni/Co/Fe, sulphide precipitation with Fe⁰) produce measurable improvements of between 7 and 18% on specific productivity when applied to the correct limiting factor. Applied without a prior diagnosis, however, more than 70% of commercial pilots do not reach 1x ROI at 12 months according to sector data. Efficacy does not depend on the product alone: it depends on the method by which it is applied.
How do you tell an additive with a technical basis from one without?
Five indicators distinguish a serious supplier from one without a technical basis: it specifies the exact biochemical mechanism on the limiting factor, provides references to peer-reviewed publications with independent authorship, proposes a specific dose per kg of VS fed (not generic), recommends a minimum 60-day pilot with justification, and signs quantitative success criteria before starting the trial. A supplier without a technical basis usually dodges at least three of these five indicators.
What questions should you ask a biogas additives supplier?
Five key questions before signing. One: which biochemical mechanism acts on the plant’s specific limiting factor. Two: which peer-reviewed publications support that mechanism. Three: what exact dose they propose and based on which variable. Four: what minimum pilot duration they recommend. Five: which quantitative criteria they sign as a success condition before starting. If the supplier does not answer these five questions concretely, the pilot is not worth accepting.
Why might an additive not work?
The three most frequent causes of failure of a well-formulated additive are: application to a limiting factor different from the one the additive is designed to resolve (organic overload, free NH3, insufficient mixing), an incorrect dose due to a lack of prior analytical characterisation, and a trial period too short to overcome the microbial adaptation time. In these three cases, the hasty conclusion “the additive doesn’t work” hides the real problem: the application method was inadequate.
Are they selling you a “magic solution” for your biogas plant?
Before signing your next pilot contract, request a Smallops Operational Excellence Diagnosis. We characterise your plant’s real limiting factor across 14 variables and tell you, with criteria, whether that additive can resolve it or whether you’ll be charged €50,000 a year for something that doesn’t act on your bottleneck.
References and standards
Romero-Güiza, M.S. et al. (2016). The role of additives on anaerobic digestion: A review. Renewable and Sustainable Energy Reviews, 58, 1486-1499. doi.org/10.1016/j.rser.2015.12.094
Choong, Y.Y. et al. (2016). Impacts of trace element supplementation on the performance of anaerobic digestion. Bioresource Technology, 209, 369-379. doi.org/10.1016/j.biortech.2016.03.028
Wang, T. et al. (2018). The roles of trace elements in anaerobic digestion. Bioresource Technology, 269, 397-407. doi.org/10.1016/j.biortech.2018.08.097
Demirel, B. & Scherer, P. (2011). Trace element requirements of agricultural biogas digesters. Biomass and Bioenergy, 35 (3), 992-998. doi.org/10.1016/j.biombioe.2010.12.022